Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite
Public ClinicalTrials.gov record NCT04677712. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
MOBI: A Phase 4, Open-Label Study to Assess Effects of Mitigation Treatments on Bruising of CCH-aaes Treatment of Buttock Cellulite in Adult Females
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will investigate treatments that may mitigate bruising after QWO™ (Collagenase clostridium histolyticum \[CCH\]-aaes) treatment of cellulite in the buttocks.
Study identification
- NCT ID
- NCT04677712
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 48 participants
Conditions and interventions
Interventions
- CCH-aaes Drug
- Compression Other
- Cold Packs Other
- Arnica Gel Drug
- INhance® Drug
- PDL Other
Drug · Other
Eligibility (public fields only)
- Age range
- 18 Years to 50 Years
- Sex
- Female
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 27, 2020
- Primary completion
- Jun 25, 2021
- Completion
- Sep 1, 2021
- Last update posted
- Aug 20, 2023
2020 – 2021
United States locations
- U.S. sites
- 8
- U.S. states
- 7
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Endo Clinical Trial Site #3 | Scottsdale | Arizona | 85255 | — |
| Endo Clinical Trial Site #2 | Sacramento | California | 95816 | — |
| Endo Clinical Trial Site #7 | San Diego | California | 92122 | — |
| Endo Clinical Trial Site #6 | Fort Collins | Colorado | 80525 | — |
| Endo Clinical Trial Site #5 | Chicago | Illinois | 60611 | — |
| Endo Clinical Trial Site #1 | Shreveport | Louisiana | 71105 | — |
| Endo Clinical Trial Site #8 | Boston | Massachusetts | 02114 | — |
| Endo Clinical Trial Site #4 | Nashville | Tennessee | 37203 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04677712, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 20, 2023 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04677712 live on ClinicalTrials.gov.